Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

CD55 Antikörper

Name: CD55 Antikörper
SKU: ABIN2480961
Price: 585.67 EUR
Availability: InStock

CD55 Reaktivität: Human FACS, WB, IP, Func Wirt: Maus Monoclonal BRIC216 unconjugated

(2 Referenzen)

Produktnummer ABIN2480961

Datenblatt (PDF)

Target Alle CD55 Antikörper anzeigen

CD55 (Complement Decay-Accelerating Factor (CD55))
Reaktivität
124

32

7

4

4

4

3

2

2

2
Human
Wirt
88

63

6

5

2

1

1
Maus
Passende Sekundärantikörper
Klonalität
101

63

2
Monoklonal
Konjugat
77

16

15

12

5

4

3

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
Dieser CD55 Antikörper ist unkonjugiert
Applikation
93

90

44

32

29

26

17

15

14

13

8

4

3

3

3

1

1

1

1
Flow Cytometry (FACS), Western Blotting (WB), Immunoprecipitation (IP), Functional Studies (Func)

Produktmerkmale

Purified IgG

Aufreinigung

Purified

Immunogen

Human fibroblast cell line

Klon

BRIC216

Isotyp

IgG1

Top Product

Discover our top product CD55 Primärantikörper
anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibody
CD55 Reaktivität: Human WB, ELISA, PLA Wirt: Maus Monoclonal 1G3 unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 35-285) antibody
CD55 Reaktivität: Human WB, ELISA, IHC (fro), ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 40-300) antibody
CD55 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 51-79) antibody
CD55 Reaktivität: Human FACS, WB, IHC, IF, ELISA Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 35-134) antibody
CD55 Reaktivität: Human WB, IF, ELISA Wirt: Maus Monoclonal 1D7 unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (Center) antibody
CD55 Reaktivität: Human WB, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) antibody
CD55 Reaktivität: Human, Non-Human Primate FACS, WB, IP, IHC (p) Wirt: Maus Monoclonal MEM-118 unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 254-372) antibody
CD55 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) (AA 35-126) antibody
CD55 Reaktivität: Human IHC, IF, ELISA Wirt: Kaninchen Polyclonal unconjugated

anti-Complement Decay-Accelerating Factor (CD55) antibody (Biotin)
CD55 Reaktivität: Human, Non-Human Primate FACS, WB, IP, IHC (p) Wirt: Maus Monoclonal MEM-118 Biotin

Applikationshinweise

Optimal working dilution should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Liquid

Konzentration

1.0 mg/mL
Loberg, Day, Dunn, Kalikin, Pienta: "Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo." in: Neoplasia (New York, N.Y.), Vol. 8, Issue 1, pp. 69-78, (2006) (PubMed).

Liszewski, Leung, Schraml, Goodship, Atkinson: "Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome." in: Molecular immunology, Vol. 44, Issue 7, pp. 1559-68, (2006) (PubMed).
Target

CD55 (Complement Decay-Accelerating Factor (CD55))

Andere Bezeichnung

CD55 (CD55 Produkte)

Hintergrund

Synonyms: DAF

Gen-ID

1604

UniProt

P08174

Pathways

Komplementsystem, Regulation of Leukocyte Mediated Immunity